Skip to main content

New Products: Mar 29, 2011


Germany's Atlas Biolabs is now a certified service provider for Roche NimbleGen's SeqCap EZ enrichment to prepare genomic DNA for sequencing.

Atlas Biolabs will now be able to offer enrichment services using both Roche's SeqCap EZ Exome kit, as well as its recently launched SeqCap EZ Choice Libraries for enrichment of custom regions of interest in a single test tube. According to the company, the new technology is ideal for targeting disease-associated regions of the genome.

The Wellcome Trust Sanger Institute has released version 52 of COSMIC, the Catalogue of Somatic Mutations in Cancer. The new version includes the curation of four new genes and 16 new fusion pairs, and updates from the International Cancer Genome Consortium and the Cancer Genome Atlas. It also integrates data from the Genomics of Drug Sensitivity in Cancer, a collaborative project between the Sanger Institute and Massachusetts General Hospital. Additionally, 21 new genes have been added to the Cancer Gene Census.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.